Category: Drug Discovery
Drug Discovery market research reports by GlobalData
-
Artificial Intelligence in Pharma - Impact, Trends, Key Players and Top AI Drugs
Artificial Intelligence in Pharma - Impact, Trends, Key Players and Top AI Drugs Summary This report investigates the impacts and development of Artificial Intelligence within the pharmaceutical industry from the standpoint of drug development. It provides a high-level analysis of key trends and mov ... Read More
-
Inflammatory Disease Markers Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies
Inflammatory Disease Markers Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies Summary GlobalData's Medical Devices sector report, “Inflammatory Disease Markers Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and K ... Read More
-
Batten Disease (BD) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Batten Disease (BD) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in BD therapeutics. Across the 16 major pharmaceutical markets, GlobalData estimates that there a ... Read More
-
Meningitis Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update
Meningitis Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update Summary GlobalData's clinical trial report, “Meningitis Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update provi ... Read More
-
Myelodysplastic Syndrome Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update
Myelodysplastic Syndrome Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update Summary GlobalData's clinical trial report, “Myelodysplastic Syndrome Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top ... Read More
-
Turner Syndrome Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update
Turner Syndrome Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update Summary GlobalData's clinical trial report, “Turner Syndrome Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Up ... Read More
-
Idiopathic Hypersomnia (IH) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Idiopathic Hypersomnia (IH) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in IH therapeutics. More than 280,000 diagnosed prevalent cases of IH are anticipated in ... Read More
-
IgA Nephropathy (Berger's Disease) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
IgA Nephropathy (Berger's Disease) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in Berger's Disease therapeutics. More than 100,000 incident cases of Berger’s Dis ... Read More
-
Neurovascular Accessory Devices Pipeline Report Including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update
Neurovascular Accessory Devices Pipeline Report Including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update Summary GlobalData's Medical Devices sector report, “Neurovascular Accessory Devices Pipeline Report including Stages of Development, Segmen ... Read More
-
Diffuse Large B-Cell Lymphoma (DLBCL) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Diffuse Large B-Cell Lymphoma (DLBCL) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in DLBCL therapeutics. More than 555,000 diagnosed prevalent cases of DLBCL are ... Read More
-
Cutaneous Squamous Cell Carcinoma (cSCC) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Cutaneous Squamous Cell Carcinoma (cSCC) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in cSCC therapeutics. More than 16 million diagnosed prevalent cases of DN a ... Read More
-
Cartilage Repair Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update
Cartilage Repair Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update Summary GlobalData's Medical Devices sector report, “Cartilage Repair Pipeline Report including Stages of Development, Segments, Region and Countries, Regu ... Read More
-
Dyslipidemia by Major Markets - Size, Trends and Drug Forecast including Epidemiology, Disease Management, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Pipeline Analysis to 2032
Dyslipidemia by Major Markets - Size, Trends and Drug Forecast including Epidemiology, Disease Management, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Pipeline Analysis to 2032 Summary This report covers the 7MM (US, France, Germany, Italy, Spain, UK, Japan) and provides an Exc ... Read More
-
Post-Traumatic Stress Disorder (PTSD) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Post-Traumatic Stress Disorder (PTSD) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in PTSD therapeutics. Scope GlobalData’s PTSD: Competitive Landscape combines d ... Read More
-
Uveitis Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2023 Update
Uveitis Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2023 Update Summary GlobalData's clinical trial report, “Uveitis Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and ... Read More
-
Systemic Sclerosis (Scleroderma) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2023 Update
Systemic Sclerosis (Scleroderma) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2023 Update Summary GlobalData's clinical trial report, “Systemic Sclerosis (Scleroderma) Clinical Trial Analysis by Trial Phase, Trial Status, Tr ... Read More
-
Autism Spectrum Disorder (ASD) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Autism Spectrum Disorder (ASD) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in ASD therapeutics. There will be over 9.8 million diagnosed prevalent cases of ASD i ... Read More
-
Atrial Fibrillation Market Size and Trend Report including Epidemiology, Disease Management, Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast to 2032
Atrial Fibrillation Market Size and Trend Report including Epidemiology, Disease Management, Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast to 2032 Summary This report covers the 8MM (US, France, Germany, Italy, Spain, UK, Japan, Canada) and provides an ... Read More
-
Atrial Fibrillation Epidemiology Analysis and Forecast to 2032
Atrial Fibrillation Epidemiology Analysis and Forecast to 2032 Summary Atrial fibrillation (AF) is the most common type of cardiac arrhythmia. It occurs due to abnormal electrical activity within the atria of the heart, causing them to fibrillate, and is characterized as a tachyarrhythmia (Wakai and ... Read More
-
Lyme Disease Tests Market Size (Value, Volume, ASP) by Segments, Share, Trend and SWOT Analysis, Regulatory and Reimbursement Landscape, Procedures, and Forecast to 2033
Lyme Disease Tests Market Size (Value, Volume, ASP) by Segments, Share, Trend and SWOT Analysis, Regulatory and Reimbursement Landscape, Procedures, and Forecast to 2033 Summary Lyme Disease Tests (In Vitro Diagnostics) - Global Market Analysis and Forecast Model (COVID-19 Market Impact) is built to ... Read More
-
Tourette Syndrome Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2023 Update
Tourette Syndrome Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2023 Update Summary GlobalData's clinical trial report, “Tourette Syndrome Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status ... Read More
-
Choroidal Neovascularization Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2023 Update
Choroidal Neovascularization Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2023 Update Summary GlobalData's clinical trial report, “Choroidal Neovascularization Clinical Trial Analysis by Trial Phase, Trial Status, Trial Coun ... Read More
-
Frozen Shoulder Syndrome Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2023 Update
Frozen Shoulder Syndrome Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2023 Update Summary GlobalData's clinical trial report, “Frozen Shoulder Syndrome Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End ... Read More
-
Dyslipidemia Epidemiology Analysis and Forecast to 2032
Dyslipidemia Epidemiology Analysis and Forecast to 2032 Summary Dyslipidemia is a medical condition characterized by the imbalance of lipids such as cholesterol, low-density lipoprotein cholesterol (LDL-C), triglycerides (TGs), and high-density lipoprotein (HDL) in the blood. Dyslipidemia is a major ... Read More
-
Narcolepsy Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Narcolepsy Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in Narcolepsy therapeutics. There will be more than 900,000 diagnosed prevalent cases of narcolepsy in 202 ... Read More
Research Assistance
